Enanta Pharmaceuticals (ENTA) PT Lowered to $44 at SVB Leerink
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $14.09 --0%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Join SI Premium – FREE
SVB Leerink analyst Roanna Ruiz lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $44.00 (from $58.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $440 at Scotiabank
- NetApp (NTAP) PT Raised to $191 at Morgan Stanley
- Snowflake Inc. (SNOW) PT Raised to $475 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
